The project is intended to treat 50 children from ages 2 to 16 living with epilepsy that have exhausted most of their treatment options, Carney said.
Every step of the three-year study will be meticulously tracked. Patients will check-in at regular intervals and the researchers will examine how the children are responding, Carney said.
All subjects will be clinically evaluated and seizure frequency will be recorded in a diary given to patients, according to the ClinicalTrials.gov [5] website.
“Through this research, we want to learn about what type of children respond, if they can tolerate the medication and if there are any side effects we need to worry about,” Carney said.
The study will begin later this summer and participants are still being accepted, Carney said.The project is intended to treat 50 children from ages 2 to 16 living with epilepsy that have exhausted most of their treatment options, Carney said.
Every step of the three-year study will be meticulously tracked. Patients will check-in at regular intervals and the researchers will examine how the children are responding, Carney said.
All subjects will be clinically evaluated and seizure frequency will be recorded in a diary given to patients, according to the ClinicalTrials.gov [5] website.
“Through this research, we want to learn about what type of children respond, if they can tolerate the medication and if there are any side effects we need to worry about,” Carney said.
The study will begin later this summer and participants are still being accepted, Carney said.
Links
[1] http://www.alligator.org/news/local/article_3d6f7a1a-0feb-11e5-ba08-47e46d4d83a9.html
[2] http://www.rethinkpot.org/tags/epidiolex
[3] http://www.rethinkpot.org/tags/orphan-study
[4] http://www.rethinkpot.org/tags/florida
[5] http://clinicaltrials.gov/